Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
$716,251.04
-1.5%
$750,457.87
$609,578.55
$812,855.00
$1.05T0.821,418 shs636 shs
Carnival Corporation stock logo
CCL
Carnival
$29.33
-2.1%
$23.56
$13.78
$30.46
$34.98B2.6125.32 million shs45.69 million shs
Novavax, Inc. stock logo
NVAX
Novavax
$6.61
-2.8%
$6.76
$5.01
$17.81
$1.10B2.696.30 million shs4.15 million shs
Principia Biopharma Inc. stock logo
PRNB
Principia Biopharma
$100.05
$100.05
$25.35
$101.89
$3.32B0.86729,676 shsN/A
Rackspace Technology, Inc. stock logo
RXT
Rackspace Technology
$1.34
-2.9%
$1.26
$1.00
$3.41
$327.60M2.06935,164 shs826,217 shs
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
$0.30
+2.6%
$0.76
$0.24
$3.10
$5.04M0.92258,504 shs1.80 million shs
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$82.34
-1.5%
$75.60
$50.15
$83.95
$272.05B1.1617.38 million shs18.15 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
-1.54%-1.61%-3.41%-2.70%+15.80%
Carnival Corporation stock logo
CCL
Carnival
-2.10%+4.19%+20.65%+75.47%+70.42%
Novavax, Inc. stock logo
NVAX
Novavax
-2.72%+4.92%-11.28%+4.75%-44.45%
Principia Biopharma Inc. stock logo
PRNB
Principia Biopharma
0.00%0.00%0.00%0.00%0.00%
Rackspace Technology, Inc. stock logo
RXT
Rackspace Technology
-0.74%+4.69%+13.56%-0.74%-51.97%
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
+1.86%-21.77%-55.87%-65.98%-77.06%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
-1.17%+2.71%+7.80%+32.83%+38.11%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
0.3719 of 5 stars
0.00.00.02.11.40.01.3
Carnival Corporation stock logo
CCL
Carnival
4.7248 of 5 stars
2.33.00.03.13.21.74.4
Novavax, Inc. stock logo
NVAX
Novavax
4.4652 of 5 stars
3.12.00.04.71.20.83.1
Principia Biopharma Inc. stock logo
PRNB
Principia Biopharma
N/AN/AN/AN/AN/AN/AN/AN/A
Rackspace Technology, Inc. stock logo
RXT
Rackspace Technology
0.5178 of 5 stars
1.92.00.00.00.01.70.0
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
4.1651 of 5 stars
3.35.00.04.70.60.01.3
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
4.758 of 5 stars
2.34.02.52.53.31.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
0.00
N/AN/AN/A
Carnival Corporation stock logo
CCL
Carnival
2.65
Moderate Buy$28.65-2.33% Downside
Novavax, Inc. stock logo
NVAX
Novavax
2.29
Hold$17.00157.19% Upside
Principia Biopharma Inc. stock logo
PRNB
Principia Biopharma
0.00
N/AN/AN/A
Rackspace Technology, Inc. stock logo
RXT
Rackspace Technology
1.75
Reduce$1.6321.89% Upside
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
2.50
Moderate Buy$3.751,147.92% Upside
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
2.65
Moderate Buy$78.33-4.88% Downside

Current Analyst Ratings Breakdown

Latest PRNB, BRK.A, UBX, WFC, NVAX, CCL, and RXT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/7/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Market Perform
7/2/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$78.00 ➝ $85.00
6/26/2025
Carnival Corporation stock logo
CCL
Carnival
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$21.00 ➝ $24.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$28.00 ➝ $30.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$33.00 ➝ $35.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$33.00 ➝ $34.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetPositive ➝ Positive$27.00 ➝ $30.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$30.00 ➝ $31.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$30.00 ➝ $33.00
6/23/2025
Carnival Corporation stock logo
CCL
Carnival
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$33.00 ➝ $34.00
6/23/2025
Carnival Corporation stock logo
CCL
Carnival
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$27.00
(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
$415.78B2.48$41,282.48 per share17.35$453,291.16 per share1.58
Carnival Corporation stock logo
CCL
Carnival
$25.02B1.37$3.89 per share7.54$8.02 per share3.66
Novavax, Inc. stock logo
NVAX
Novavax
$682.16M1.57N/AN/A($3.89) per share-1.70
Principia Biopharma Inc. stock logo
PRNB
Principia Biopharma
$35.16M94.50N/AN/A$10.95 per share9.14
Rackspace Technology, Inc. stock logo
RXT
Rackspace Technology
$2.74B0.12$4.32 per share0.31($4.41) per share-0.30
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
$240K21.55N/AN/A$0.39 per share0.77
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$81.58B3.28$8.23 per share10.01$48.79 per share1.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
$89.00B$56,289.7012.72N/A21.79%7.20%4.01%N/A
Carnival Corporation stock logo
CCL
Carnival
$1.92B$1.8515.8514.030.669.72%27.88%5.20%N/A
Novavax, Inc. stock logo
NVAX
Novavax
-$187.50M$2.652.4982.630.0638.14%-115.51%29.99%8/14/2025 (Estimated)
Principia Biopharma Inc. stock logo
PRNB
Principia Biopharma
-$53.79M-$2.09N/AN/AN/AN/A-23.08%-21.11%N/A
Rackspace Technology, Inc. stock logo
RXT
Rackspace Technology
-$858.20M-$1.28N/AN/A-10.82%N/A-1.55%8/6/2025 (Estimated)
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
-$25.99M-$1.62N/AN/AN/AN/A-246.82%-58.81%7/22/2025 (Estimated)
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$19.72B$5.5714.7811.991.4016.19%12.15%1.03%7/15/2025 (Estimated)

Latest PRNB, BRK.A, UBX, WFC, NVAX, CCL, and RXT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
-$0.30N/AN/AN/AN/AN/A
7/15/2025Q2 2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.41N/AN/AN/A$20.83 billionN/A
6/24/2025Q2 2025
Carnival Corporation stock logo
CCL
Carnival
$0.24$0.35+$0.11$0.42$6.20 billion$6.33 billion
5/8/2025Q1 2025
Novavax, Inc. stock logo
NVAX
Novavax
$0.71$2.93+$2.22$2.93$204.08 million$666.66 million
5/8/2025Q1 2025
Rackspace Technology, Inc. stock logo
RXT
Rackspace Technology
-$0.08-$0.06+$0.02-$0.31$657.98 million$665.40 million
4/22/2025Q1 2025
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
-$0.43-$0.43N/A-$0.43N/AN/A
4/11/2025Q1 2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.23$1.39+$0.16$1.39$20.82 billion$20.15 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
N/AN/AN/AN/AN/A
Carnival Corporation stock logo
CCL
Carnival
N/AN/AN/AN/AN/A
Novavax, Inc. stock logo
NVAX
Novavax
N/AN/AN/AN/AN/A
Principia Biopharma Inc. stock logo
PRNB
Principia Biopharma
N/AN/AN/AN/AN/A
Rackspace Technology, Inc. stock logo
RXT
Rackspace Technology
N/AN/AN/AN/AN/A
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
N/AN/AN/AN/AN/A
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.601.94%N/A28.73%4 Years

Latest PRNB, BRK.A, UBX, WFC, NVAX, CCL, and RXT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/29/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
quarterly$0.402.28%5/9/20255/9/20256/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
N/A
0.32
0.32
Carnival Corporation stock logo
CCL
Carnival
2.58
0.34
0.30
Novavax, Inc. stock logo
NVAX
Novavax
N/A
2.06
2.03
Principia Biopharma Inc. stock logo
PRNB
Principia Biopharma
N/A
17.01
17.01
Rackspace Technology, Inc. stock logo
RXT
Rackspace Technology
N/A
0.79
0.79
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
N/A
1.95
1.95
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
1.06
0.84
0.84
CompanyEmployeesShares OutstandingFree FloatOptionable
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
372,0001.44 million1.43 millionNot Optionable
Carnival Corporation stock logo
CCL
Carnival
100,0001.17 billion1.08 billionOptionable
Novavax, Inc. stock logo
NVAX
Novavax
1,990161.97 million160.35 millionOptionable
Principia Biopharma Inc. stock logo
PRNB
Principia Biopharma
6533.21 millionN/ANot Optionable
Rackspace Technology, Inc. stock logo
RXT
Rackspace Technology
5,100237.39 million230.51 millionOptionable
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
6017.21 million16.21 millionOptionable
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
217,0003.25 billion3.25 billionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Berkshire Hathaway stock logo

Berkshire Hathaway NYSE:BRK.A

$716,251.04 -11,203.96 (-1.54%)
As of 07/7/2025 03:59 PM Eastern

Berkshire Hathaway Inc., through its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses worldwide. It provides property, casualty, life, accident, and health insurance and reinsurance; and operates railroad systems in North America. The company also generates, transmits, stores, and distributes electricity from natural gas, coal, wind, solar, hydro, nuclear, and geothermal sources; operates natural gas distribution and storage facilities, interstate pipelines, liquefied natural gas facilities, and compressor and meter stations; and holds interest in coal mining assets. In addition, the company manufactures boxed chocolates and other confectionery products; specialty chemicals, metal cutting tools, and components for aerospace and power generation applications; and flooring, insulation, roofing and engineered, building and engineered components, paints and coatings, and bricks and masonry products, as well as offers manufactured and site-built home construction, and related lending and financial services; and recreational vehicles, apparel products, jewelry, and custom picture framing products, and alkaline batteries. Further, it manufactures castings, forgings, fasteners/fastener systems, and aerostructures; and seamless pipes, fittings, downhole casing and tubing, and various mill forms. Additionally, the company distributes televisions and information; franchises and services quick service restaurants; distributes electronic components; and offers logistics services, grocery and foodservice distribution services, and professional aviation training and shared aircraft ownership programs. It also retails automobiles; furniture, bedding, and accessories; household appliances, electronics, and computers; jewelry, watches, crystal, china, stemware, flatware, gifts, and collectibles; kitchenware; and motorcycle apparel and equipment. The company was incorporated in 1998 and is headquartered in Omaha, Nebraska.

Carnival stock logo

Carnival NYSE:CCL

$29.33 -0.63 (-2.10%)
Closing price 07/7/2025 03:59 PM Eastern
Extended Trading
$29.24 -0.08 (-0.29%)
As of 07/7/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Novavax stock logo

Novavax NASDAQ:NVAX

$6.61 -0.19 (-2.79%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$6.60 -0.01 (-0.15%)
As of 07/7/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Principia Biopharma stock logo

Principia Biopharma NASDAQ:PRNB

Principia Biopharma Inc., a late-stage biopharmaceutical company, focuses on developing novel therapies for immunology and oncology. The company is developing PRN1008, an inhibitor that is in Phase III clinical trial for the treatment of pemphigus, a chronic skin disease, as well as in Phase II clinical trial to treat immune thrombocytopenic purpura. It is also developing PRN2246/SAR442168, an inhibitor, which has completed Phase I clinical trial for treating multiple sclerosis (MS) and other central nervous system (CNS) diseases; PRN1371, a drug candidate that is in Phase I clinical trial for the treatment of solid tumors; and oral small molecule inhibitors of the immunoproteasome. The company has a collaboration agreement with Genzyme Corporation to develop relapsing and progressive MS and other diseases of the CNS. Principia Biopharma Inc. was incorporated in 2008 and is headquartered in South San Francisco, California.

Rackspace Technology stock logo

Rackspace Technology NASDAQ:RXT

$1.34 -0.04 (-2.90%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$1.39 +0.05 (+3.66%)
As of 07/7/2025 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rackspace Technology, Inc. operates as a multi cloud technology services company in the Americas, Europe, the Middle East, Africa, and The Asia-Pacific region. It operates through three segments: Multicloud Services, Apps & Cross Platform, and OpenStack Public Cloud. The company provides public and private cloud managed services, which allow customers to determine, manage, and optimize the right infrastructure, platforms, and services; professional services related to designing and building multi cloud solutions and cloud-native applications; and managed hosting and colocation services. It also helps customers establish governance, operational, and architectural frameworks to mitigate risks and reduce inefficiencies to manage costs, achieve industry-specific compliance objectives, and enhance security. In addition, the company offers managed applications, including running large-scale SaaS applications for customers on its and public cloud infrastructure; managed security services in the areas of security threat assessment and prevention, threat detection and response, rapid remediation, governance, and risk and compliance assistance across multiple cloud platforms, as well as privacy and data protection services, including detailed access restrictions and reporting; data services; and professional services related to designing and implementing application, security, and data services. Rackspace Technology, Inc. was founded in 1998 and is headquartered in San Antonio, Texas.

UNITY Biotechnology stock logo

UNITY Biotechnology NASDAQ:UBX

$0.30 +0.01 (+2.59%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$0.29 -0.01 (-3.16%)
As of 07/7/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2048, a Tie2/VEGF bispecific; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

Wells Fargo & Company stock logo

Wells Fargo & Company NYSE:WFC

$82.34 -1.26 (-1.51%)
Closing price 07/7/2025 03:59 PM Eastern
Extended Trading
$82.14 -0.20 (-0.24%)
As of 07/7/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.